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Abstract
With the advent of high-throughput technologies for measuring genome-wide expression profiles, a large number of
methods have been proposed for discovering diagnostic markers that can accurately discriminate between different classes
of a disease. However, factors such as the small sample size of typical clinical data, the inherent noise in high-throughput
measurements, and the heterogeneity across different samples, often make it difficult to find reliable gene markers. To
overcome this problem, several studies have proposed the use of pathway-based markers, instead of individual gene
markers, for building the classifier. Given a set of known pathways, these methods estimate the activity level of each
pathway by summarizing the expression values of its member genes, and use the pathway activities for classification. It has
been shown that pathway-based classifiers typically yield more reliable results compared to traditional gene-based
classifiers. In this paper, we propose a new classification method based on probabilistic inference of pathway activities. For a
given sample, we compute the log-likelihood ratio between different disease phenotypes based on the expression level of
each gene. The activity of a given pathway is then inferred by combining the log-likelihood ratios of the constituent genes.
We apply the proposed method to the classification of breast cancer metastasis, and show that it achieves higher accuracy
and identifies more reproducible pathway markers compared to several existing pathway activity inference methods.
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Introduction
The introduction of affordable microarray technologies for
measuring genome-wide expression profiles has led to the
development of numerous methods for discriminating between
different classes of a complex disease, such as cancer, through
transcriptome analysis [1–4]. Especially, there have been signif-
icant research efforts to identify differentially expressed genes
across different phenotypes [5–9], which can be used as diagnostic
markers for classifying the disease states or predicting the outcome
of medical treatments [1–4,10–12]. However, finding reliable gene
markers is a challenging problem, and several recent studies have
questioned the reliability of many classifiers based on individual
gene markers [13–19]. The small sample size of typical clinical
data that are used to build a classifier is one of the major factors
that make this problem difficult. We often have to search for a
small number of good marker genes among thousands of genes
based on a limited number of samples, which makes the
performance of traditional feature selection methods quite
unpredictable [20]. The inherent measurement noise in high-
throughput experimental data and the heterogeneity across
samples and patients make the problem even more formidable.
One possible way to address this problem is to interpret the
expression data at the level of functional modules, such as signaling
pathways and molecular complexes, instead of at the level of
individual genes. In fact, one of the weaknesses of many gene-
based classification methods is that the marker genes are often
selected independently, even though their functional products may
interact with each other. Therefore, the selected gene markers may
contain redundant information, and they may not synergistically
improve the overall classification performance. We can alleviate
this problem by jointly analyzing the expression levels of groups of
functionally related genes, which can be obtained based on
transcriptome analysis [21–23], GO annotations [24], or other
sources. In fact, several studies [23,25–28] have shown that
pathway markers are more reproducible compared to single gene
markers and they can provide important biological insights into
the underlying mechanisms that lead to different disease
phenotypes. Furthermore, pathway-based classifiers often achieve
comparable or better classification performance compared to
traditional gene-based classifiers.
To use pathway-based markers in classification, we need a way
to infer the activity of a given pathway based on the expression
levels of the constituent genes. Recently, a number of pathway
activity inference methods have been proposed for this purpose.
For example, Guo et al. [25] proposed to use the mean or median
expression value of the member genes to infer the pathway
activity. Tomfohr et al. [28] and Bild et al. [23] used the first
principal component of the expression profile of the member genes
to estimate the activity of a given pathway. More recently, Lee et
al. [26] proposed a method that predicts the pathway activity using
only a subset of genes in the pathway, called the condition-
responsive genes (CORGs), whose combined expression levels can
accurately discriminate the phenotypes of interest.
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In this paper, we propose a novel method for probabilistic
inference of pathway activities. For a given pathway, the proposed
method estimates the log-likelihood ratio between different
phenotypes based on the expression level of each member gene.
The activity level of the pathway is then inferred by combining the
log-likelihood ratios of the genes that belong to the pathway. We
apply our method to the classification of breast cancer metastasis,
and demonstrate that it can achieve higher accuracy compared to
several previous pathway-based approaches. Furthermore, we
show that the proposed pathway activity inference method can
find more reproducible pathway markers that retain the
discriminative power across different datasets.
Methods
Datasets
We obtained two independent breast cancer datasets from
large-scale gene expression studies by Wang et al. [11] (referred as
the ‘‘USA’’ dataset in this work) and van’t Veer et al. [10] (referred
as the ‘‘Netherlands’’ dataset). Wang et al.’s dataset [11] contains
the gene expression profiles of 286 breast cancer patients from the
USA, where metastasis was detected in 107 of them while the
remaining 179 were metastasis-free. The other dataset studied by
van’t Veer et al. [10] contains the gene expression profiles of 295
patients from the Netherlands, where 79 had metastasis and 216
were metastasis-free. In this study, we did not consider the follow-
up time or the occurrence of distant metastasis.
To obtain the set of known biological pathways, we referred to
the MSigDB (Molecular Signatures Database) version 2.4 (updated
April 7, 2008) [21]. We downloaded the canonical pathways in the
C2 curated gene sets, which contains 639 gene sets obtained from
several pathway databases, including the KEGG (Kyoto Encyclo-
pedia of Genes and Genomes) database [29] and the GenMAPP
[30]. These gene sets are compiled by domain experts and they
provide canonical representations of biological processes. The set
of pathways obtained from the MSigDB covers more than 5,000
distinct genes, where 3,271 of them can be found in both
microarray platforms used by the two breast cancer gene
expression studies in [10,11].
Probabilistic Inference of Pathway Activity
For each pathway, we first identified the genes that were
included in the expression profiles in the two breast cancer
datasets. The genes that were not included in these datasets were
removed from the gene set for the given pathway. Consider a
pathway that contains n genes G~ g1, g2, . . . , gnf g after remov-
ing the genes whose expression values were not available. Given a
sample xj~ x
1
j ,x
2
j , . . . ,x
n
j
 
that contains the expression levels of
the member genes, we estimate the pathway activity aj as follows
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where f 1i xð Þ is the conditional probability density function (PDF)
of the expression level of gene gi under phenotype 1, and f
2
i xð Þ
is the conditional PDF under phenotype 2. The ratio li x
i
j
 
is a
probabilistic indicator that tells us which phenotype is more likely
based on the expression level xij of the ith member gene gi. We
combine the evidence from all the member genes to infer the
overall pathway activity aj~
Pn
i~1 li x
i
j
 
. The pathway activity
aj can serve as a discriminative score for classifying the sample xj
into different phenotypes based on the activation level of the given
pathway. Conceptually, we can view this approach as computing
the relative support for the two different phenotypes using a Naive
Bayes model [31,32] based on the gene expression profile of the
pathway.
In order to compute the LLR value li x
i
j
 
, we need
to estimate the PDF f ci xð Þ for each phenotype c[ 1,2f g. We
assume that the gene expression level of gene gi under phenotype c
follows a Gaussian distribution with mean mci and standard
deviation sci . These parameters were estimated based on all
available samples xij that correspond to the phenotype c. The
estimated PDFs can then be used for computing the log-likelihood
ratios. In practical applications, we often do not have enough
training data for reliable estimation of the PDFs f 1i xð Þ and f 2i xð Þ.
This may make the computation of LLRs sensitive to small
changes in the gene expression profile. To avoid this problem, we
normalize the li x
i
j
 
as follows
bli xij
 
~
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i
j
 
{m lið Þ
s lið Þ , ð3Þ
where m lið Þ and s lið Þ are the mean and standard deviation of
li x
i
j
 
across all samples, respectively. Figure 1 illustrates the
overall procedure for inferring the activity of a given pathway.
Discriminative Power of Pathway Markers
In order to compare the proposed pathway activity inference
scheme with other existing methods, we performed the
following experiments. In our first experiment, we selected the
top 50 differentially expressed pathways using the method
proposed by Tian et al. [22]. To assess the ability of a given
pathway in discriminating between different phenotypes, Tian
et al. computes the t-test statistics scores for all member genes
and take their average to compute an aggregated score T that
can serve as an indicator of the pathway’s discriminative power.
After prescreening the top 50 pathways that have the largest
absolute T values, we computed the activity score for each of
these pathways using the proposed inference method as well as
other methods. The obtained pathway activity scores were then
used to compute the t-test statistics score for each pathway
marker. The t-test scores were used to assess the discriminative
power of pathway markers and to compare different inference
methods.
In this work, we compared five different pathway activity
inference methods: the mean and the median methods [25], the
PCA-based method [23,28], the CORG-based method [26], and
the inference method proposed in this paper. For the mean,
median, and CORG-based methods, we computed the score T
by averaging the t-test scores of the expression values of the
member genes. For the PCA-based method, we computed T by
averaging the absolute t-test scores of the gene expression values,
since the PCA can naturally combine expression values
regardless of whether they are positively correlated or negatively
correlated with the phenotype of interest. For our proposed
method, we computed T by averaging the t-test scores of the
LLRs of the member genes, since we estimated the pathway
Pathway-Based Classification
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activity score based on LLRs instead of the original expression
values.
We also evaluated the robustness of each inference method in
identifying good pathway markers, by ranking the pathways using
one of the two breast cancer datasets, and then assessing the
discriminative power of the pathways based on the other dataset.
Again, t-test statistics of the pathway activity scores were used to
compare different inference methods.
In our second experiment, we computed the t-test statistics
scores for all 639 pathways without any prescreening, and
compared the effectiveness of different pathway activity inference
methods based on the computed scores. As in the first experiment,
we also evaluated the robustness of each inference method for
finding effective pathway markers, by ranking the pathways
according to the t-test scores estimated using one of the datasets,
and then evaluating their discriminative power on the other
dataset.
Evaluation of Classification Performance
In order to evaluate the classification performance of the
proposed pathway activity inference method, we performed the
following cross-validation experiments.
For within-dataset experiments, the samples in a dataset were
randomly divided into five subsets of equal size, where the samples
in four of these subsets were used for training the classifier and the
remaining subset was used for assessing the classification
performance. This has been repeated by using each subset as
the test set to obtain more reliable results. The training set was
divided again into three equal-sized subsets. Two thirds were used
for ranking the pathway markers and building the classifier (the
‘‘marker-evaluation’’ dataset), and one third of the training set was
used for feature selection (the ‘‘feature-selection’’ dataset). All
samples in the training set were used to estimate the PDFs of the
gene expression values under different phenotypes. To build the
classifier, we evaluated each pathway based on the discriminative
power of its activity score to classify samples. The pathways were
sorted in increasing order of the p-value. After ranking the
pathways, we built the classifier, either based on logistic regression
or LDA (linear discriminant analysis), as follows. Based on the
marker-evaluation dataset, we first constructed the classifier with
only one feature, namely, the pathway marker with the lowest p-
value. The performance of the classifier was then measured by
computing the AUC (Area Under ROC Curve) [33] on the
feature-selection dataset. Next, we enlarged the set of features by
selecting the pathway marker with the lowest p-value among the
remaining pathways. A new classifier was trained using the
selected features on the marker-evaluation dataset and its
classification performance was again assessed on the feature-
selection dataset. The added pathway marker was kept in the
feature set if the AUC increased, and it was removed otherwise.
Figure 1. Probabilistic inference of pathway activity. For each gene in the pathway, we estimate the conditional probability density functions
(PDFs) under different phenotypes. Based on the estimated PDFs, we transform the expression values of the member genes into log-likelihood ratios
(LLRs) to obtain a LLR matrix from the gene expression matrix. The LLR matrix is then normalized, and the pathway activity is inferred by combining
the normalized LLRs of its member genes.
doi:10.1371/journal.pone.0008161.g001
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We repeated the above process for all pathway markers to
optimize the classifier. The performance of the optimized classifier
was evaluated by computing the AUC on the test dataset. These
experiments have been repeated for 100 random partitions of the
entire dataset. We report the AUC, averaged over 500
experiments, as the overall performance measure of the classifi-
cation method at hand. The overall process of the within-dataset
experiment is illustrated in Fig. 2A.
In order to evaluate the reproducibility of the pathway markers
across different dataset, we performed cross-dataset experiments,
where one dataset was used for selecting the pathway markers,
and the other dataset was used for building the classifier based on
the selected markers and evaluating its performance. First, we
selected the optimal set of features (i.e., pathway markers) based on
one dataset, by optimizing the AUC metric. The process for
selecting the feature set was similar to the one used in the within-
dataset experiments. The samples in the other dataset were
divided into five subsets of equal size. Four fifths of samples were
used to train the classifier using the selected features, and one fifth
of samples were used to evaluate the performance of the
constructed classifier. We repeated this experiment by using each
of the five subsets as the test set and using the rest for training. The
above experiment was repeated for 100 random partitions of the
entire dataset, and the average AUC over the 500 experiments was
reported as the performance measure. It is important to note that
feature selection is performed solely based on the first dataset.
During the cross-validation experiments using the second dataset,
the training set (that consists of four fifths of samples in the same
dataset) is simply used to build the classifier based on the
preselected set of features. The overall goal of these cross-dataset
experiments is to evaluate the reproducibility of the feature set,
selected using the proposed pathway activity inference scheme,
across different datasets. Figure 2B illustrates the overall process of
the cross-dataset experiment.
To compare the proposed method with other existing methods,
we performed the described within-dataset experiments and the
cross-dataset experiments using other pathway activity inference
methods (mean, median, PCA, and CORG). In addition, we also
evaluated the performance of a gene-based classifier that uses
individual genes as diagnostic markers, following a similar
procedure. In this study, we included the top 50 pathway markers
in the initial marker set, which were selected according to the
method in Tian et al. [22] as elaborated in the previous subsection.
For the gene-based classifier, we included the top 50 gene markers
with the lowest p-values in the initial marker set, in order to keep
the maximum number of features identical.
Computing the Area under ROC Curve
In this work, we evaluated the performance of a classifier based
on the AUC (Area Under ROC Curve). The AUC metric has
been widely used for evaluating classification methods, since it can
provide a useful summary statistics of the classification perfor-
mance over the entire range of specificity and sensitivity values. To
compute the AUC, we adopted the method proposed in [33]. For
a given classifier, let x1,x2, . . . ,xm be the output of the classifier for
positive samples, and let y1,y2, . . . ,yn be the output for negative
samples. Then, the AUC metric A for the classifier is given by:
A~
1
mn
Xm
i~1
Xn
j~1
I xiwyj
 
, ð4Þ
where I :ð Þ is the indicator function. The AUC is actually the
empirical probability that a randomly chosen positive sample is
ranked higher than a randomly chosen negative sample. It can be
shown that the AUC measure is equivalent to the Mann-Whitney
U -test (also called the Wilcoxon rank-sum test) statistics.
Results
Probabilistic Pathway Activity Inference Improves the
Discriminative Power of Pathway Markers
We evaluated the discriminative power of pathway markers,
where the pathway activities were inferred using the proposed
method as well as other inference methods. For effective
comparison of the proposed inference method with other existing
methods, we carried out similar experiments as those performed
in [26] to assess the discriminative power of pathway markers. For
each breast cancer dataset, we first used the method of Tian et al.
[22] to select the top 50 pathways among the 639 pathways
obtained from the MSigDB [21] (see Methods). We computed the
actual activity scores of the top 50 pathways based on each
pathway activity inference scheme, and ranked the pathways
according to their discriminative power. Figure 3 shows the
discriminative power of the top pathways, where the x-axis
corresponds to the number k of top pathways that were
Figure 2. Illustration of the experimental set-up. (A) In the within-dataset experiments, part of the training set, referred as the marker-
evaluation set, is used for ranking the pathway markers according to their discriminative power and building the classifier. The optimal set of features
are selected based on the remainder of the training set, referred as the feature-selection set. The performance of the resulting classifier is evaluated
using the test dataset. (B) In the cross-dataset experiments, one of the datasets is used to find the optimal set of features, and the other dataset is
used to build a classifier based on the preselected features and to evaluate the classifier.
doi:10.1371/journal.pone.0008161.g002
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considered, and the y-axis shows the mean absolute t-score of the
top k pathways. We compared five pathway activity inference
methods, namely, the CORG-based method [26], PCA-based
method [23,28], mean and median methods [25], and the LLR-
based method proposed in this paper. For comparison, we also
evaluated the discriminative power of the top 50 single gene
markers, which were chosen among the 3,271 genes covered by
the 639 pathways used in this study. The results obtained from the
Netherlands breast cancer dataset [10] and the USA breast cancer
dataset [11] are shown in Fig. 3A and Fig. 3B, respectively. As we
can see from these results, the proposed pathway activity
inference scheme, which computes the pathway activity score
by combining the log-likelihood ratios of the member genes,
significantly improved the power of pathway markers to
discriminate between metastatic samples and non-metastatic
samples. Interestingly, the top gene markers often compared
favorably to pathway markers. On the Netherlands dataset, the
expression levels of the top genes had larger discriminative power
than the pathway activity scores inferred by the CORG, PCA,
mean, and median methods. Only the pathway activity scores
estimated by the proposed method were more discriminative than
the gene expression values. On the USA dataset, gene markers
were more discriminative than pathway markers based on mean,
median, and PCA methods, but less discriminative compared to
pathway markers based on the proposed method and the CORG
method.
To evaluate the reproducibility of pathway markers, we ranked
the markers based on one dataset and evaluated their mean
absolute t-score using the other dataset. Figure 3C shows the result
for ranking the markers based on the Netherlands dataset and
computing the mean absolute t-score of the top k markers using
the USA dataset. Similarly, Fig. 3D shows the result for ranking
the markers based on the USA dataset and computing the mean
score of the top k pathways using the Netherlands dataset. These
results clearly show that the pathway markers selected based on
the proposed inference method retain significantly large discrim-
inative power across different datasets. In fact, in both cross-
dataset experiments, the pathway activity scores computed by the
LLR method were much more discriminative than the activity
scores computed by other inference methods as well as the
expression values of the top gene markers. Altogether, these results
imply that the proposed method can find better diagnostic markers
with higher reproducibility. Also note that the single gene markers,
which had considerably large discriminative power within a
dataset (see Figs. 3A and 3B), lost most of the discriminative power
in a different dataset.
Figure 3. Discriminative power of prescreened pathway markers and single gene markers. (A) Mean absolute t-score of the top
k ~10,20,30,40,50ð Þ markers for the Netherlands breast cancer dataset. Pathway activities have been inferred using five different methods: CORG,
PCA, mean, median, and LLR (proposed method). The discriminative power of the top gene markers was estimated for comparison (labeled as
‘‘Gene’’). (B) Mean absolute t-score of the top markers for the USA breast cancer dataset. (C) The markers were ranked based on the Netherlands
dataset and the mean absolute t-score of the top k markers was computed based on the USA dataset. (D) The markers were ranked based on the USA
dataset and the mean absolute t-score of the top markers was computed based on the Netherlands dataset.
doi:10.1371/journal.pone.0008161.g003
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Next, we performed similar experiments for all 639 pathways
and all 3,271 genes covered by these pathways, without any
prescreening (see Methods). The results of these experiments are
shown in Fig. 4, where the x-axis indicates the ratio P% of the top
pathways that were used to compute the mean absolute t-score,
and the y-axis corresponds to the estimated mean absolute t-score
of the top P% pathways. The discriminative power of the pathway
markers and the single gene markers on the Netherlands dataset is
shown in Fig. 4A, and the discriminative power of the markers on
the USA dataset is shown in Fig. 4B. The results obtained from
cross-dataset experiments are summarized in Fig. 4C and 4D. In
Fig. 4C, the markers were ranked according to their discriminative
power on the Netherlands set, and their mean absolute t-scores
were computed using the USA dataset. The results for ranking the
markers based on the USA dataset and computing the scores using
the Netherlands set are shown in Fig. 4D. All these experiments
show that the pathway activity scores measured by the proposed
LLR method are much more discriminative than the scores
computed by other inference methods and also the expression
values of individual genes. Furthermore, we can see that the
pathway markers that were chosen based on the LLR-based
pathway activity scores are more reproducible and their activity
scores retain significant amount of discriminative capability across
independent datasets.
Proposed Pathway Activity Inference Scheme Leads to
More Accurate and Reliable Classifiers
We used the proposed pathway activity inference scheme for
classification of breast cancer metastasis, to evaluate its usefulness
in discriminating different cancer phenotypes. For a fair and
effective comparison with other inference schemes, we again
adopted a similar experimental set-up that was used in [26] to
evaluate the performance of the CORG-based method, a state-of-
the-art pathway activity inference scheme that uses only the
condition-responsive genes in a given pathway. For each breast
cancer dataset, we performed five-fold cross-validation experi-
ments, where four fifths of samples were used for constructing the
classifier and the remaining one fifth of samples were used for
evaluating the classification performance (see Methods). While
constructing the classifier, we used the LLR-based pathway
activity inference method for assessing the discriminative power
of each pathway marker and selecting the optimal set of markers to
be used in the classifier. The constructed classifier also used the
pathway activity scores computed by the proposed inference
method to distinguish metastatic breast cancer samples from non-
metastatic samples. In our experiments, we defined the initial set of
pathway markers as the top 50 pathways selected using the
method by Tian et al. [22] (see Methods). We assessed the
classification performance using the AUC metric. We repeated the
Figure 4. Discriminative power of all pathway markers and gene markers. (A) Mean absolute t-score of the top P% markers for the
Netherlands dataset. (B) Mean absolute t-score of the top markers for the USA dataset. (C) The markers were ranked based on the Netherlands dataset
and the mean absolute t-score of the top P% markers was computed based on the USA dataset. (D) The markers were ranked based on the USA
dataset and the mean score of the top P% markers was computed based on the Netherlands dataset.
doi:10.1371/journal.pone.0008161.g004
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five-fold cross-validation for 100 random partitions of the given
dataset, and averaged the resulting 500 AUCs to obtain a reliable
performance measure of the classification method. To compare
the classification performance of different inference methods, we
also repeated the previous experiments using the CORG, PCA,
mean, and median methods for inferring the pathway activities.
For comparison, we also evaluated the performance of the gene-
based classification method. We included the top 50 discriminative
genes in the initial marker set, to keep the maximum number of
features identical for all classification methods.
Figure 5 summarizes the results of the cross-validation
experiments. In the first set of experiments, we used logistic
regression for classifying the samples. The classification results of
different approaches based on logistic regression are shown in
Fig. 5A. The two bar charts on the left of Fig. 5 correspond to the
two within-dataset experiments based on the USA breast cancer
dataset (labeled as ‘‘USA’’) and the Netherlands dataset (labeled as
‘‘Netherlands’’), respectively. In these within-dataset experiments,
the initial set of top 50 markers have been selected using the entire
dataset, in order to reduce the effect of sensitivity in marker
Figure 5. Performance of different classification methods. The bar charts show the average AUCs for different classification methods. Five
pathway-based methods that use distinct pathway activity inference schemes (LLR, CORG, PCA, mean, and median) and a gene-based method were
compared. (A) Classifiers were constructed based on logistic regression. Results of within-dataset experiments based on the USA and Netherlands
datasets are shown in the two charts on the left. The two charts on the right show the results of the cross-dataset experiments. (B) The performance
of different classification methods based on LDA (linear discriminant analysis).
doi:10.1371/journal.pone.0008161.g005
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selection when comparing different pathway-based methods. The
cross-validation experiments have been performed based on the
selected initial set of markers (see Methods). As we can see in these
bar charts, the proposed method achieved the highest classification
accuracy among all methods, in both experiments. The CORG-
based method compared favorably to other pathway-based
methods, though outperformed by the proposed method. We
can also see that the gene-based classifier performed very well in
within dataset experiments, which is not surprising if we consider
the high discriminative power of the top gene markers observed in
Figs. 3A and 3B.
The results of the cross-dataset experiments are shown in the
two bar charts on the right of Fig. 5A. The chart labeled as ‘‘USA-
Netherlands’’ shows the results for selecting the features using the
USA dataset, and training/evaluating the classifier using the
Netherlands dataset. Similarly, the chart labeled as ‘‘Netherlands-
USA’’ shows the classification performance for choosing the
feature set using the Netherlands dataset, and training and
evaluating the classifier based on the USA dataset. As we can see,
the proposed LLR-based method outperformed most of the other
methods in both cross-dataset experiments. Only the mean-based
approach showed better performance than the proposed approach
on the Netherlands-USA cross-dataset experiment. These results
show that the proposed pathway activity inference method can
find a better feature set that is more reproducible across datasets,
compared to other activity inference methods. Despite the good
performance in within-dataset experiments, gene-based classifiers
performed typically worse than many pathway-based classifiers,
which shows the poor reproducibility of the feature sets based on
individual gene markers.
We also repeated the entire experiments using LDA (linear
discriminant analysis), instead of logistic regression, for building
the classifiers. The results are shown in Fig. 5B, where we can see
similar trends as in Fig. 5A. The proposed classification method
yielded the highest classification accuracy in both within-dataset
experiments, and it also outperformed other methods in cross-
dataset experiments, with the only exception of the mean-based
inference method in one of the experiments.
Finally, in order to analyze the overall effect of preselecting the
initial marker set, we carried out another set of within-dataset
experiments, where the initial markers were reselected in every
experiment using only the designated training data. The
classification results are shown in Fig. 6A and 6B for logistic
regression and LDA, respectively. As we can see from these
figures, the preliminary marker selection step has important
influence on the overall classification results, where the sensitivity
of the selection method may adversely affect the performance of
the resulting classifiers. However, as we can see from Fig. 6, the
relative performance between different classification methods
showed similar tendency as in the previous set of experiments
(see Fig. 5), and the proposed method consistently outperformed
the other methods in all experiments.
Proposed Method Leads to Robust Classifiers That Yield
Symmetric Results for Dataset Inversion
Ultimately, we want to construct a robust classifier that yields
accurate and consistent classification results on independent gene
expression datasets. Given two independent datasets of similar
size, where one dataset is used for training the classifier and the
other dataset is used for evaluation, a robust classification scheme
would show consistent classification performance if the training set
were interchanged with the test set. However, the USA breast
cancer dataset [11] and the Netherlands dataset [10] had been
obtained from different microarray platforms and also prepro-
cessed using different methods, which makes it practically difficult
to evaluate the robustness of the proposed classification method by
training the classifier based on one of the datasets and evaluating
its performance on the other dataset. For this reason, we
performed the following two-fold cross-validation experiments to
assess the robustness of the proposed approach. First, we randomly
divided a given dataset into two subsets of equal size. One of the
subsets was used to build an actual classifier based on LDA with a
classification threshold of lth~0:5. The classifier was then used to
classify the samples in the other subset and the classification error
rate was computed. Next, we interchanged the training set and the
test set and repeated the previous experiment. In order to find out
Figure 6. Performance of different classification methods. The bar charts show the average AUCs of within-dataset experiments for five
pathway-based methods (LLR, CORG, PCA, mean, and median) and a gene-based method. In these experiments, the top 50 pathways have been
reselected in every experiment using the designated training set. (A) Classification results based on logistic regression. (B) Classification results based
on LDA (linear discriminant analysis).
doi:10.1371/journal.pone.0008161.g006
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whether we can obtain consistent classification performance after
interchanging the training and test sets, we computed the absolute
difference between the two classification error rates. We repeated
this experiment for 250 random partitions of each breast cancer
dataset, and estimated the distribution of the absolute error
difference. For comparison, we carried out the above experiments
using the proposed pathway activity inference scheme as well as
the CORG-based scheme [26]. The proposed classification
scheme resulted in a relatively small average error difference of
0.0414 on the USA dataset, and 0.0324 on the Netherlands
dataset. The CORG-based classification scheme yielded a slightly
higher error difference, whose average was 0.0429 for the USA
dataset and 0.0345 for the Netherlands dataset. Figure 7 shows the
cumulative distribution of the classification error difference on the
two datasets for the respective methods. These results indicate that
both pathway-based classification schemes can lead to the
construction of robust classifiers that yield consistent results on
different datasets, where the proposed scheme compares favorably
to the CORG-based scheme.
Discussion
In this paper, we have proposed a novel probabilistic pathway
activity inference scheme that estimates the activation level of a
pathway based on the log-likelihood ratios (LLRs) of the member
genes. The proposed method can effectively address several
shortcomings of the previous pathway activity inference methods,
thereby improving the discriminative power of the pathway
markers. For example, the methods proposed by Guo et al. [25]
estimate the pathway activity by taking the mean or median of the
gene expression values of the member genes. These methods
cannot effectively capture the coherent gene expression patterns
that may be present within a pathway. For example, suppose a
member gene is positively correlated with a phenotype of interest,
while another gene in the same pathway is negatively correlated
with the given phenotype. In this case, we may lose much of the
discriminative information contained in the respective gene
expression values if we average them out. The PCA-based
inference method used in a number of studies [23,28] can
somewhat relieve this problem. In the PCA approach, the first
basis vector captures the average expression pattern of the
member genes, and the first principal component can estimate
the presence and the strength of this pattern in a gene expression
profile. However, not all the member genes may alter their
expression levels under different phenotypes in a consistent
manner. In fact, some genes may have expression changes that
are irrelevant to the phenotypic change of our interest. To address
this problem, Lee et al. [26] proposed a new pathway activity
inference method that uses only a subset of member genes, called
CORGs (condition-responsive genes), whose combined expression
levels are highly discriminative of the phenotypes. However, the
CORG-method may disregard member genes that have consis-
tent, but not large, expression changes under different phenotypes.
The proposed LLR-based method provides an effective solution
to these problems. First of all, by using the LLR of a member gene,
instead of directly using its expression value, the proposed method
can capture the consistent gene expression changes that are related
to the phenotypic change. Moreover, since the LLR is computed
based on the difference in distribution of the gene expression
values under different conditions, the direction and the amount of
expression changes do not have large effects on the overall
discriminative power of the pathway marker. Furthermore, the
proposed method fully utilizes the available discriminative
information in all the member genes, not just some of them; and
it naturally weights and combines the support from each member
gene in a given pathway to increase the discriminative power of
the corresponding pathway marker. As we have demonstrated in
this paper, the LLR-based pathway activity inference scheme
significantly improves the discriminative power of the pathway
markers, increases the overall classification accuracy, and finds
reliable pathway markers that are more reproducible across
different datasets. Therefore, the proposed method may ultimately
lead to the construction of more reproducible classifiers. The two-
fold cross-validation experiments, where we measured the change
in classification error that resulted from interchanging the training
Figure 7. Robustness of the proposed classification scheme. To assess the robustness of the proposed classification scheme, two-fold cross-
validation experiments have been performed, where we measured the change in classification error after interchanging the training and test sets. (A)
Cumulative distribution of the error difference for the USA dataset. (B) Cumulative distribution of the error difference for the Netherlands dataset.
doi:10.1371/journal.pone.0008161.g007
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and test sets, demonstrated the potential of the proposed scheme
for building robust and reproducible classifiers.
Currently, one limitation of the pathway-based classifiers is the
limited coverage of genes by known biological pathways. We
believe that the classification performance of the pathway-based
methods will be considerably improved once we have a more
complete list of biological pathways. One possible way to
overcome this problem is to identify effective pathway (or
subnetwork) markers by overlaying a protein-protein interaction
(PPI) network with gene expression data and searching for
significantly differentially expressed regions in the given network,
as proposed in [34]. In this work, we assumed that the expression
values of a gene follows a Gaussian distribution. Although this has
been shown to be a good approximation in our experiments, using
alternative distributions that better fit the expression data may
further improve the overall classification performance. For
example, we may consider using gamma distributions as proposed
by Efroni et al. [35].
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